I started my Insights career at a medical devices division of one of the ...
As the drug landscape grows increasingly competitive, it will be vital to gain an ...
Since 2020, diversity, equity, and inclusion (DE&I) has been a prime area of attention ...
In many respects, the arrival of generative artificial intelligence (AI) represents an entirely expected ...
An initial and discernible benefit to adopting decentralized clinical trial (DCT) models is alleviating ...
According to the National Organization for Rare Disorders (NORD), there are over 7,000 known ...
The world is full of tradeoffs—it’s the way progress is made while proportionately managing ...
Getting clinical trials to the finish line is not easy. Between 15% to 40% ...
PM360 asked experts in clinical trials about the evolution of decentralized research and what ...
Clinical trial protocol writing teams usually start with scientific objectives, and ideally with the ...
Patients’ directly reported outcomes in certain rare and chronic diseases are considered reliable for ...
In the pharmaceutical business, as with any other business, you can’t market what you ...
Selecting the right Contract Research Organization (CRO) for your clinical trial is a common ...